The Readout Loud

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(417)

Episode #8 - Megamergers, migraines, and biotech's Four Horsemen

Episode #8 - Megamergers, migraines, and biotech's Four Horsemen

What's a good use of $64 billion? Is Big Biotech boring now? And what's the best way to sell hair restoration products to men?

26 Apr 201825min

Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism

Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism

Is Bristol-Myers Squibb into self-sabotage? Is Congress coming for Gut Guy? And why does Goldman Sachs love money so much?

19 Apr 201821min

Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR

Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR

Why are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged hellhound bent on destroying Chicago?

12 Apr 201823min

Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr

Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr

What's it like to be a biotech investor? Do you know where your genetic data are? And what does it mean when the FDA swipes left on your drug?

5 Apr 201822min

Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card

Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card

Why aren't pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter? And why is there no Kelley Blue Book for the price tag of a medicine?

29 Mar 201823min

Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?

Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?

What’s it like to watch gene therapy happen? Is the next big cancer clinical trial going to work? And is “right to try” going to defang the FDA?

22 Mar 201824min

Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies

Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies

Did Elizabeth Holmes get off easy? Why does biotech bother with SXSW? And what does shoving a tube into a dead cow’s throat have to do with biotech?

15 Mar 201821min

Episode #1 - Shkreli's sentence, biotech froth, and a blood party

Episode #1 - Shkreli's sentence, biotech froth, and a blood party

How long is Martin Shkreli going to be in prison? Is the biotech bubble about to burst? And what's it like to attend a blood-swapping gala? Listen to our first episode of, "The Readout LOUD."

8 Mar 201818min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
lydartikler-fra-aftenposten
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
pengepodden-2
rss-orjasater
utbytte
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
pengesnakk
stormkast-med-valebrokk-stordalen
lederpodden
morgenkaffen-med-finansavisen
liberal-halvtime
rss-markedspuls-2